Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 628 | 617 | 654 | 256 | 250 |
| Accounts receivable | -2,507 | 1,372 | -1,307 | -1,827 | -389 |
| Other Working Capital | 3,389 | -6,449 | -6,755 | 1,399 | -1,678 |
| Other Operating Activity | -2,184 | -6,632 | -3,704 | -1,971 | -4,378 |
| Operating Cash Flow | $-674 | $-11,092 | $-11,112 | $-2,143 | $-6,195 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -237 | -101 | -42 | -60 | -118 |
| Purchase Sale Intangibles | 0 | -75 | 4,999 | -11,499 | -14 |
| Investing Cash Flow | $-237 | $-176 | $4,957 | $-11,559 | $-132 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | -3,218 | 38,025 | 0 |
| Debt Repayment | -57 | -50 | 3,618 | -385 | -604 |
| Common Stock Issued | 0 | N/A | -393 | 313 | 80 |
| Other Financing Activity | 0 | 0 | -48 | -1,595 | -39 |
| Financing Cash Flow | $-57 | $-50 | $-41 | $36,358 | $-563 |
| Exchange Rate Effect | 133 | -229 | 975 | -160 | 23 |
| Beginning Cash Position | 10,954 | 22,501 | 27,722 | 5,226 | 12,093 |
| End Cash Position | 10,119 | 10,954 | 22,501 | 27,722 | 5,226 |
| Net Cash Flow | $-968 | $-11,318 | $-6,196 | $22,656 | $-6,890 |
| Free Cash Flow | |||||
| Operating Cash Flow | -674 | -11,092 | -11,112 | -2,143 | -6,195 |
| Capital Expenditure | -237 | -176 | N/A | -11,559 | -132 |
| Free Cash Flow | -911 | -11,268 | -11,112 | -13,702 | -6,327 |